BS10 Canagliflozin, an SGLT2 inhibitor attenuates ischaemia/reperfusion injury in the non-diabetic heart | Heart

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via BCS

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Article metrics

Basic Science

BS10 Canagliflozin, an SGLT2 inhibitor attenuates ischaemia/reperfusion injury in the non-diabetic heart

Free

Online download statistics by month:

Online download statistics by month: May 2019 to March 2024

	Abstract	Full	Pdf
May 2019	8	0	4
Jun 2019	30	0	14
Jul 2019	23	0	5
Aug 2019	20	0	2
Sep 2019	18	0	1
Oct 2019	25	0	1
Nov 2019	16	0	0
Dec 2019	44	0	8
Jan 2020	50	0	2
Feb 2020	86	0	5
Mar 2020	94	0	2
Apr 2020	69	0	8
May 2020	69	0	5
Jun 2020	23	0	3
Jul 2020	17	0	4
Aug 2020	2	0	3
Sep 2020	32	0	4
Oct 2020	20	0	5
Nov 2020	16	0	3
Dec 2020	8	0	3
Jan 2021	20	0	8
Feb 2021	10	0	5
Mar 2021	20	0	11
Apr 2021	8	0	2
May 2021	8	0	3
Jun 2021	0	0	2
Jul 2021	0	0	7
Aug 2021	0	0	4
Sep 2021	0	0	1
Oct 2021	6	0	16
Nov 2021	10	0	12
Dec 2021	6	0	2
Jan 2022	20	0	0
Feb 2022	8	0	1
Mar 2022	2	0	1
Apr 2022	6	0	1
May 2022	14	0	10
Jun 2022	4	0	2
Jul 2022	36	0	1
Aug 2022	34	0	4
Sep 2022	10	0	4
Oct 2022	4	0	3
Nov 2022	12	0	1
Dec 2022	10	0	0
Jan 2023	6	0	1
Feb 2023	10	0	1
Mar 2023	8	0	0
Apr 2023	22	0	1
May 2023	10	0	3
Jul 2023	4	0	5
Aug 2023	8	0	2
Sep 2023	16	0	0
Oct 2023	10	0	0
Nov 2023	8	0	2
Dec 2023	16	0	2
Jan 2024	6	0	1
Feb 2024	2	0	0
Mar 2024	2	0	44
Total	1046	0	245